285 related articles for article (PubMed ID: 21360410)
1. Microwave-assisted synthesis of 2(1H)-pyridones and their glucosides as cell proliferation inhibitors.
Al-Neyadi SS; Hassan AH; Abdou IM
Nucleosides Nucleotides Nucleic Acids; 2011 Feb; 30(2):120-34. PubMed ID: 21360410
[TBL] [Abstract][Full Text] [Related]
2. Efficient microwave-assisted synthesis and antitumor activity of novel 4,4'-methylenebis[2-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)phenols].
Insuasty B; García A; Quiroga J; Abonia R; Ortiz A; Nogueras M; Cobo J
Eur J Med Chem; 2011 Jun; 46(6):2436-40. PubMed ID: 21481989
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents.
Lv Z; Zhang Y; Zhang M; Chen H; Sun Z; Geng D; Niu C; Li K
Eur J Med Chem; 2013 Sep; 67():447-53. PubMed ID: 23920246
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
Poreba K; Wietrzyk J; Opolski A
Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
[TBL] [Abstract][Full Text] [Related]
5. SPF32629A and SPF32629B: enantioselective synthesis, determination of absolute configuration, cytotoxicity and antibacterial evaluation.
Vegi SR; Boovanahalli SK; Patro B; Mukkanti K
Eur J Med Chem; 2011 May; 46(5):1803-12. PubMed ID: 21397370
[TBL] [Abstract][Full Text] [Related]
6. A novel series of cytotoxic iridoid glucosides derived from aucubin: design, synthesis and structure-activity relationships.
Rakotondramasy VC; Mouriès C; Cachet X; Neghra A; El Mourabet M; Tillequin F; Koch M; Deguin B
Eur J Med Chem; 2010 Jun; 45(6):2314-20. PubMed ID: 20227146
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxic activity of (E)-1-(2-nitrovinyl) and 1-[N-(tert-butylformiminyl)]-substituted 1,4-dihydropyridines and 2-pyridones.
Im C; Knaus EE; Thuynsma RP; Allen TM
Drug Des Deliv; 1990 Mar; 5(3):239-48. PubMed ID: 1670504
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity.
Wittman M; Carboni J; Attar R; Balasubramanian B; Balimane P; Brassil P; Beaulieu F; Chang C; Clarke W; Dell J; Eummer J; Frennesson D; Gottardis M; Greer A; Hansel S; Hurlburt W; Jacobson B; Krishnananthan S; Lee FY; Li A; Lin TA; Liu P; Ouellet C; Sang X; Saulnier MG; Stoffan K; Sun Y; Velaparthi U; Wong H; Yang Z; Zimmermann K; Zoeckler M; Vyas D
J Med Chem; 2005 Sep; 48(18):5639-43. PubMed ID: 16134929
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives.
El-Said MS; El-Gazzar MG; Al-Dosari MS; Ghorab MM
Arzneimittelforschung; 2012 Mar; 62(3):149-56. PubMed ID: 22270843
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs.
Chen T; Luo Y; Hu Y; Yang B; Lu W
Eur J Med Chem; 2013 Jun; 64():613-20. PubMed ID: 23708235
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, crystal structure and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives.
Zheng LW; Zhu J; Zhao BX; Huang YH; Ding J; Miao JY
Eur J Med Chem; 2010 Dec; 45(12):5792-9. PubMed ID: 20947221
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and structure-activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents.
Farag AM; Ali KA; El-Debss TM; Mayhoub AS; Amr AG; Abdel-Hafez NA; Abdulla MM
Eur J Med Chem; 2010 Dec; 45(12):5887-98. PubMed ID: 20950898
[TBL] [Abstract][Full Text] [Related]
13. Regiospecific microwave-assisted synthesis and cytotoxic activity against human breast cancer cells of (RS)-6-substituted-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or -9H-purines.
Conejo-García A; Núñez MC; Marchal JA; Rodríguez-Serrano F; Aránega A; Gallo MA; Espinosa A; Campos JM
Eur J Med Chem; 2008 Aug; 43(8):1742-8. PubMed ID: 18069093
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of antiproliferative activity by molecular simplification of catalpol.
García C; León LG; Pungitore CR; Ríos-Luci C; Daranas AH; Montero JC; Pandiella A; Tonn CE; Martín VS; Padrón JM
Bioorg Med Chem; 2010 Apr; 18(7):2515-23. PubMed ID: 20231098
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase.
Li R; Xue L; Zhu T; Jiang Q; Cui X; Yan Z; McGee D; Wang J; Gantla VR; Pickens JC; McGrath D; Chucholowski A; Morris SW; Webb TR
J Med Chem; 2006 Feb; 49(3):1006-15. PubMed ID: 16451066
[TBL] [Abstract][Full Text] [Related]
16. Microwave-assisted synthesis, crystal structure of pyrazolo[1,5-a]pyrazin-4(5H)-ones and their selective effects on lung cancer cells.
Liu N; Zhang JH; Zhao BX; Zhao J; Su L; Dong WL; Zhang SL; Miao JY
Eur J Med Chem; 2011 Jun; 46(6):2359-67. PubMed ID: 21463913
[TBL] [Abstract][Full Text] [Related]
17. Is the reactivity of M(II)-arene complexes of 3-hydroxy-2(1H)-pyridones to biomolecules the anticancer activity determining parameter?
Hanif M; Henke H; Meier SM; Martic S; Labib M; Kandioller W; Jakupec MA; Arion VB; Kraatz HB; Keppler BK; Hartinger CG
Inorg Chem; 2010 Sep; 49(17):7953-63. PubMed ID: 20704358
[TBL] [Abstract][Full Text] [Related]
18. 4-anilino-5-carboxamido-2-pyridone derivatives as noncompetitive inhibitors of mitogen-activated protein kinase kinase.
Spicer JA; Rewcastle GW; Kaufman MD; Black SL; Plummer MS; Denny WA; Quin J; Shahripour AB; Barrett SD; Whitehead CE; Milbank JB; Ohren JF; Gowan RC; Omer C; Camp HS; Esmaeil N; Moore K; Sebolt-Leopold JS; Pryzbranowski S; Merriman RL; Ortwine DF; Warmus JS; Flamme CM; Pavlovsky AG; Tecle H
J Med Chem; 2007 Oct; 50(21):5090-102. PubMed ID: 17880056
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-tumor activities of methyl 2-O-aryl-6-O-aryl'-D-glucopyranosides.
Shi H; Zhou B; Li W; Shi Z; Yu B; Wang R
Bioorg Med Chem Lett; 2010 May; 20(9):2855-8. PubMed ID: 20356741
[TBL] [Abstract][Full Text] [Related]
20. Cdc7 kinase inhibitors: pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationships.
Vanotti E; Amici R; Bargiotti A; Berthelsen J; Bosotti R; Ciavolella A; Cirla A; Cristiani C; D'Alessio R; Forte B; Isacchi A; Martina K; Menichincheri M; Molinari A; Montagnoli A; Orsini P; Pillan A; Roletto F; Scolaro A; Tibolla M; Valsasina B; Varasi M; Volpi D; Santocanale C
J Med Chem; 2008 Feb; 51(3):487-501. PubMed ID: 18201066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
